Article
Evaluation of the BCL-2 gene locus as a susceptibility locus linked to the clinical expression of systemic lupus erythematosus (SLE).
Rheumatology international - 1 Jan 1996
Huang Q R, Morris D, Manolios N
Abstract excerpt
Systemic lupus erythematosus (SLE) is an autoimmune disease characterised by the production of a large number of autoantibodies. It has been postulated that this may be the result of prolonged longevity of auto-reactive B cells due to defective regulation of programmed cell death (apoptosis). The proto-oncogene bcl-2 is involved in the control of apoptosis in immunocompetent cells, and its over-expression is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
